Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 2797 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Read this article


    Article Cited by others


Off label use of lithium in the treatment of Huntington's disease: A case series

Danivas Vijay, Moily Nagaraj S, Thimmaiah Rohini, Muralidharan Kesavan, Purushotham Meera, Muthane Uday, Jain Sanjeev

Year : 2013| Volume: 55| Issue : 1 | Page no: 81-83

   This article has been cited by
1 A mitochondrial basis for Huntington’s disease: therapeutic prospects
J. Chakraborty,U. Rajamma,K. P. Mohanakumar
Molecular and Cellular Biochemistry. 2014; 389(1-2): 277-291
[Pubmed]  [Google Scholar] [DOI]
2 Current therapeutic options for Huntingtonæs disease: Good clinical practice versus evidence-based approaches?
Annie Killoran,Kevin M. Biglan
Movement Disorders. 2014; 29(11): 1404
[Pubmed]  [Google Scholar] [DOI]
3 Neuroprotective effects of psychotropic drugs in huntingtonæs disease
Lauterbach, E.C.
International Journal of Molecular Sciences. 2013; 14(11): 22558-22603
[Pubmed]  [Google Scholar]
4 Neuroprotective Effects of Psychotropic Drugs in Huntington’s Disease
Edward Lauterbach
International Journal of Molecular Sciences. 2013; 14(11): 22558
[Pubmed]  [Google Scholar] [DOI]